We are live on ! Find out more
TENX icon

Tenax Therapeutics

21 hedge funds and large institutions have $35.8M invested in Tenax Therapeutics in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

31% more funds holding

Funds holding: 1621 (+5)

12% less capital invested

Capital invested by funds: $40.6M → $35.8M (-$4.77M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
2
Reduced
1
Closed
1
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
-$12.2M

TENX Hedge Fund Activity: Q3 2015 in Review

21 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2015, worth a combined $35.8M — down 12% from $40.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new TENX positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Commerzbank Aktiengesellschaft, opening a new position worth an estimated $2.63M. The largest seller was Sabby Management, cutting an estimated $343K.

  • 21 institutional investors held Tenax Therapeutics (TENX) as of Q3 2015, up from 16 in Q2 2015.
  • Funds reported $35.8M of Tenax Therapeutics stock for Q3 2015, down 12% quarter-over-quarter.
  • 6 funds opened new Tenax Therapeutics positions in Q3 2015 and 1 closed out, a net change of +5 holders.
  • The largest Tenax Therapeutics buyer in Q3 2015 was Commerzbank Aktiengesellschaft, an estimated $2.63M added.
  • The largest Tenax Therapeutics seller in Q3 2015 was Sabby Management, an estimated $343K sold.

Based on aggregated 13F filings for Q3 2015.